BMI |
body mass index |
C/T |
chemotherapy |
C/T + local R/T |
combined chemotherapy and local radiotherapy |
CA19-9 |
carbohydrate antigen 19-9 |
CC |
cancer cachexia |
CI |
confidence interval |
CS + adj |
conversion surgery with pre- or post-operative adjuvant chemotherapy |
CT |
computed tomography |
EMRs |
electronic medical records |
Hb |
hemoglobin |
HR |
hazard ratio |
HU |
hounsfield unit |
IRB |
Institutional Review Board |
L3 |
the third lumbar vertebrae |
mOS |
median overall survival |
mPFS |
median progression-free survival |
Non-CC |
negative cancer cachexia status |
Non-SC |
negative sarcopenia status |
OR |
odds ratio |
OS |
overall survival |
PC |
pancreatic cancer |
PFS |
progression-free survival |
SC |
sarcopenia |
SO |
sarcopenic obesity |
TPA |
total psoas area |